Clinical Trial Supplies Market Forecasts Growth from $5.7 Billion (2025) to $10.7 Billion by 2033, Profiling Thermo Fisher Scientific, Catalent, Almac Group, UPS Healthcare & 6 Other Key Players

The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, expanding at a CAGR of 8.4%. Growth is driven by rising R&D investments, increasing chronic disease prevalence, and demand for specialized logistics for biologics, personalized medicine, and decentralized trials. Key players include Thermo Fisher Scientific, Catalent, Almac Group, and UPS Healthcare.